Phyllodes tumors of the breast: Correlation of nucleolar organizer regions with histopathological malignancy grading, flow cytometric DNA analysis and clinical outcome

To examine whether nucleolar organizer regions detected by argyrophilia (Ag‐NOR counts) can be used as a prognostic indicator in phyllodes tumors of the breast, and to compare its usefulness with that of DNA flow cytometric analysis, 28 cases of breast phyllodes tumors (including 15 benign, two bord...

Full description

Saved in:
Bibliographic Details
Published inPathology international Vol. 51; no. 11; pp. 866 - 873
Main Authors Samaratunga, Hemamali, Clarke, Belinda, Owen, Leigh, Bryson, Greg, Swanson, Cheryl
Format Journal Article
LanguageEnglish
Published Melbourne, Australia Blackwell Science Pty 01.11.2001
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To examine whether nucleolar organizer regions detected by argyrophilia (Ag‐NOR counts) can be used as a prognostic indicator in phyllodes tumors of the breast, and to compare its usefulness with that of DNA flow cytometric analysis, 28 cases of breast phyllodes tumors (including 15 benign, two borderline and 11 malignant tumors) were subjected to Ag‐NOR staining and counting as well as DNA flow cytometric analysis. S‐phase fraction and DNA ploidy analysis showed useful trends for improving outcome predictions in malignant phyllodes tumors. However, high Ag‐NOR counts were significant in predicting survival status (P= 0.013) and reached near statistical significance in predicting survival times (P= 0.07). In predicting survival status, results for Ag‐NOR counts were significantly better than those for ploidy analysis (P= 0.02) and S‐phase fraction (P< 0.01). Only S‐phase fraction was significantly predictive of survival times (P= 0.025). It is concluded that Ag‐NOR counts and DNA flow cytometric analysis, easily performed using paraffin sections, give information that can improve predictions made by histopathological classification. Ag‐NOR counts are significant in predicting survival in the presence of histopathological features of malignancy.
Bibliography:istex:261618DC8752601FD6ED285231B7254CBFBB80AF
ArticleID:PIN1294
ark:/67375/WNG-MVKGD1Q2-G
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1320-5463
1440-1827
DOI:10.1046/j.1440-1827.2001.01294.x